Dr. Hidehito Horinouchi, MD, PhD

Claim this profile
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
3 drugs studied

Area of expertise

1

Lung Cancer

Hidehito Horinouchi, MD, PhD has run 1 trial for Lung Cancer. Some of their research focus areas include:

Stage III
ALK negative
EGFR negative
2

Non-Small Cell Lung Cancer

Hidehito Horinouchi, MD, PhD has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage III
ALK negative
EGFR negative

Clinical Trials Hidehito Horinouchi, MD, PhD is currently running

More about Hidehito Horinouchi, MD, PhD

Clinical Trial Related

3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Hidehito Horinouchi, MD, PhD has experience with

  • Domvanalimab
  • Durvalumab
  • Placebo

Breakdown of trials Hidehito Horinouchi, MD, PhD has run

Non-Small Cell Lung Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Hidehito Horinouchi, MD, PhD specialize in?

Is Hidehito Horinouchi, MD, PhD currently recruiting for clinical trials?

Are there any treatments that Hidehito Horinouchi, MD, PhD has studied deeply?

What is the best way to schedule an appointment with Hidehito Horinouchi, MD, PhD?

Is there any support for travel costs?